Skip to main content
SpringerLink
Log in

Ocular Chloramphenicol and Aplastic Anaemia

Is There a Link?

  • Leading Article
  • Published:
Drug Safety Aims and scope Submit manuscript

Summary

The question of a link between the use of topical ocular chloramphenicol and the incidence of aplastic anaemia continues to be a controversial issue in ophthalmological spheres. At present topical ocular chloramphenicol is widely used in the UK for the treatment of conjunctivitis, whereas it is very rarely prescribed for this indication in the US. Individual policies vary around the rest of the world.

The evidence for and against any association between topical ocular chloramphenicol and an increased risk of aplastic anaemia is reviewed, and the reasons behind the current prescribing policies are clarified. The discussion generated in the literature over the past 2 years over this issue is considered, along with the published debate from the past 3 decades.

The debate is not conclusive, but by presenting or referencing the specific case reports and the published opinions of various experts, we hope to enable the reader to make his or her own informed decision as to whether use of the topical preparation of chloramphenicol should be considered by the ophthalmological community.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Doona M, Walsh JB. Use of chloramphenicol as topical eye medication: time to cry halt? BMJ 1995; 310: 1217–8

    Article  PubMed  CAS  Google Scholar 

  2. Kucers A. Current position of chloramphenicol chemotherapy. J Antimicrob Chemother 1980; 6: 1–9

    Article  PubMed  CAS  Google Scholar 

  3. Scott JL, Finegold SM, Belkin GA, et al. A controlled double-blind study of the hematological toxicity of chloramphenicol N Engl J Med 1965; 272: 1137–42

    Article  PubMed  CAS  Google Scholar 

  4. Best WR. Chloramphenicol associated blood dyscrasias. A review of cases submitted to the American Medical Association Registry. JAMA 1967; 201: 99–106

    Article  Google Scholar 

  5. Schwartz RM, Dayhoff MO. Origins of prokaryotes, eukaryotes, mitochondria and chloroplasts. Science 1978; 199: 395–403

    Article  PubMed  CAS  Google Scholar 

  6. Wellerstein RO, Condit PK, Kasper CK, et al. Statewide study of chloramphenicol therapy and fatal aplastic anaemia. JAMA 1969; 208: 2045–50

    Article  Google Scholar 

  7. Rosenthal RL, Blackman A. Bone marrow hypoplasia following the use of chloramphenicol eye drops. JAMA 1965; 191: 36–7

    Google Scholar 

  8. Carpenter G. Chloramphenicol eye drops and marrow aplasia. Lancet 1975; II: 326–7

    Article  Google Scholar 

  9. Abrams SM, Degnan TJ, Vinciguerra V. Marrow aplasia following topical application of chloramphenicol eye ointment. Arch Intern Med 1980; 140: 576–7

    Article  PubMed  CAS  Google Scholar 

  10. Fraunfelder FT, Bagby GC, Kelly DJ. Fatal aplastic anaemia following topical application of ophthalmic chloramphenicol. Am J Ophthalmol 1982; 93: 356–60

    PubMed  CAS  Google Scholar 

  11. Fraunfelder FT, Morgan RL, Yunis AA. Blood dyscrasias and topical ophthalmic chloramphenicol Am J Ophthalmol 1993; 115: 812–3

    PubMed  CAS  Google Scholar 

  12. Flach AJ. Fatal aplastic anaemia following topical administration of ophthalmic chloramphenicol. Am J Ophthalmol 1982; 94: 420

    Article  PubMed  CAS  Google Scholar 

  13. Saettone MF, Bucci M, Speiser P, editors. Ophthalmic drug delivery biopharmaceutical, technological and clinical aspects. Ficlia Research Series, Vol. 11. Italy: Liviana Press, 1987

    Google Scholar 

  14. Beasley H, Boltralik JJ, Baldwin HA. Chloramphenicol in aqueous humour after topical application. Arch Ophthalmol 1975; 93: 184–5

    Article  PubMed  CAS  Google Scholar 

  15. Trope GE, Lawrence JR, Hind VM, et al. Systemic absorption of topically applied chloramphenicol eye drops. Br J Ophthalmol 1979; 63(10): 690–1

    Article  PubMed  CAS  Google Scholar 

  16. Stevens JD, Mission GP. Ophthalmic use of chloramphenicol. Lancet 1987; II: 1456

    Article  Google Scholar 

  17. Hall AV, Das SS, Tabaqchali S. Is it time to stop using chloramphenicol on the eye? Risk is low in short courses [letter]. BMJ 1995; 311: 450–1

    Article  PubMed  CAS  Google Scholar 

  18. Mulla RJ, Barnes R, Rogers TR, et al. Is it time to stop using chloramphenicol on the eye? Fears based on only six cases [letter]. BMJ 1995; 311: 450

    Article  PubMed  CAS  Google Scholar 

  19. Sevilla TF, Alegre J, Vallespie T, et al. Adult pure cell aplasia following topical ocular chloramphenicol. Br J Ophthalmol 1990; 74: 640

    Article  Google Scholar 

  20. Issaragrisil S, Piankjagum A. Aplastic anaemia following topical administration of ophthalmic chloramphenicol. J Med Assoc Thai 1985; 68: 305

    Google Scholar 

  21. Gordon-Smith EC, Marsh JCW, Geary CG, et al. Is it time to stop using chloramphenicol on the eye? Prospective study of aplastic anaemia should give definitive answer [letter]. BMJ 1995; 311: 451

    Article  PubMed  CAS  Google Scholar 

  22. Becamusca FW, Bastiaensen LA. Blood dyscrasias and topically applied chloramphenicol in ophthalmology. Doc Ophthalmol 1986; 64: 87–95

    Article  Google Scholar 

  23. Buckley RJ, Kirkness CM, Kanski JJ, et al. Is it time to stop using chloramphenicol on the eye? Safe in patients with no history of blood dyscrasia [letter]. BMJ 1995; 311: 450

    Article  PubMed  CAS  Google Scholar 

  24. Doona M, Walsh JB. Is it time to stop using chloramphenicol on the eye? Reply. BMJ 1995; 311: 451

    Article  Google Scholar 

  25. ‘No substance’ to chloramphenicol alarm. Pharm J 1995; 254: 686

  26. ‘Further support for ocular chloramphenicol’. Pharm J 1995; 255: 292

    Google Scholar 

  27. ‘How serious are the hazards of ophthalmic chloramphenicol?’ North West Regional Drug Info Service 1995 June

Download references

Author information

Authors and Affiliations

  1. Immunology Department, Royal Postgraduate Medical School, Hammersmith Hospital, Du Cane Road, London, W12 0NN, England

    Sandra A. Rayner

  2. Contact Lens Department, Moorfields Eye Hospital, London, England

    Roger J. Buckley

Authors
  1. Sandra A. Rayner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roger J. Buckley
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rayner, S.A., Buckley, R.J. Ocular Chloramphenicol and Aplastic Anaemia. Drug-Safety 14, 273–276 (1996). https://doi.org/10.2165/00002018-199614050-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199614050-00001

Keywords

Search

Navigation